USPTO serial 79238225
PENC
Reviewed by CopyMark Law Group
Reg. 5815845Status 709
- Filing date
- Status date
- Registration date
- Jul 30, 2019
- Examiner
- PARKS, KIMBERLY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PENC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John C. McElwaine
John C. McElwaine NELSON MULLINS RILEY & SCARBOROUGH LLP301 S. College Street23rd Floor, IP DepartmentCharlotte, NC 28202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations and substances for use as pharmaceutical intermediates; chemical products for use in pharmaceuticals | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical, medicinal and veterinary preparations and substances for the treatment of cancer, neoplastic diseases and multiple myeloma; chemical preparations for medical use for the treatment of cancer, neoplastic diseases and multiple myeloma; drug delivery agents in the form of conjugates that facilitate the delivery of pharmaceutical preparations | SECTION 71 - CANCELLED | — |
| 042 | Pharmaceutical research services; biomedical research services; chemical research services; development of pharmaceutical preparations and medicines; laboratory research and analysis services in the field of pharmaceuticals for the treatment of cancer, neoplastic diseases and multiple myeloma; laboratory testing services in the field of pharmaceuticals for the treatment of cancer, neoplastic diseases and multiple myeloma; medical laboratory services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oncopeptides AB
- Other trademarks owned by Oncopeptides AB
- Other trademarks owned by Oncopeptides AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named PENC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 13, 2026 | C71T | CANCELLED SECTION 71 | — |
| Jul 30, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 6, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 18, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 18, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 30, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 30, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 18, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 14, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 14, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 1, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 1, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 24, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 3, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 3, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 3, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 27, 2019 | ALIE | ASSIGNED TO LIE | — |
| Mar 19, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 26, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 26, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 26, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 25, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 17, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 13, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 9, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |